Cargando...
Immune Checkpoint PD-1/PD-L1: Is There Life Beyond Antibodies?
[Image: see text] The PD-1/PD-L1 interaction has emerged as a significant target in cancer immunotherapy. Current medications include monoclonal antibodies, which have shown impressive clinical results in the treatment of several types of tumors. The cocrystal structure of human PD-1 and PD-L1 is ex...
Guardado en:
| Publicado en: | Angew Chem Int Ed Engl |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6280658/ https://ncbi.nlm.nih.gov/pubmed/29178534 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/anie.201710407 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|